References
- Seow A., Koh W. P., Chia K. S., Shi L. M., Lee H. P., Shanmugaratnam K. Trends in Cancer Incidence in Singapore 1968–2002. Singapore Cancer Registry, Singapore 2004, Report No. 6 2004
- Ng E. H., Ng F. C., Tan P. H., et al. Results of intermediate measures from a population‐based randomised trial of mammographic screening prevalence and detection of breast carcinoma among Asian women – The Singapore Breast Screening Project. Cancer 1998; 82: 1521–8
- Tan P. H., Chiang G. S. C., Ng E. H., Low S. C., Ng F. C. Pathology of screen detected cancers: findings of the Singapore Breast Screening Project. Breast 1999; 8: 120–5
- Thike A. A., Chng M. J., Fook‐Chong S., Tan P. H. Immunohistochemical expression of hormone receptors in invasive breast cancer: correlation of results of H‐score with pathologic parameters. Pathology 2001; 33: 21–5
- Greene F. L., Page D. L., Fleming I. D., et al. AJCC Cancer Staging Handbook 6. Springer, Berlin 2002
- National Health Service Breast Screening Programme (NHSBSP) and Royal College of Pathologists (UK). Pathology Reporting of Breast Disease, , et al. Sheffield, NHS Cancer Screening Programmes 2005, NHSBSP publication no. 58
- Albain K. S., Allred D. C., Clark G. M. Breast cancer outcome and predictors of outcome: are there age differentials?. J Natl Cancer Inst Monogr 1994; 16: 35–42
- Nixon A. J., Neuberg D., Hayes D. F., et al. Relationship of patient age to pathologic features of the tumour and prognosis for patients with stage I or II breast cancer. J Clin Oncol 1994; 12: 888–94
- Bonnier P., Romain S., Charpin C., et al. Age as a prognostic factor in breast cancer: relationship to pathologic and biologic features. Int J Cancer 1995; 62: 138–44
- Bertheau P., Steinberg S. M., Merino M. J. cerbB2, p53, and nm23 gene product expression in breast cancer in young women: immunohistochemical analysis and clinicopathologic correlation. Hum Pathol 1998; 29: 323–9
- Largent J. A., Ziogas A., Anton‐Culver H. Effect of reproductive factors on stage, grade and hormona receptor status in early‐onset breast cancer. Breast Cancer Res 2005; 7: 541–54
- Goldstein N. S., Vicini F. A., Kestin L. L., Thomas M. Differences in the pathologic features of ductal carcinoma in situ of the breast based on patient age. Cancer 2000; 88: 2553–60
- Vrieling C., Collette L., Fourquet A., et al. Can patient‐, treatment‐ and pathology‐related characteristics explain the high local recurrence rate following breast‐conserving therapy in young patients?. Eur J Cancer 2003; 39: 932–44
- Zhou P., Recht A. Young age and outcome for women with early‐stage invasive breast carcinoma. Cancer 2004; 101: 1264–74
- Dawson A. E., Mulford C. K., Taylor A. S., Logan‐Young W. Breast carcinoma detection in women age 35 years and younger: mammography and diagnosis by fine needle aspiration cytology. Cancer 1998; 84: 163–8
- Rosen P. P., Lesser M. L., Kinne D. W., Beattie E. J. Breast carcinoma in women 35 years of age or younger. Ann Surg 1984; 199: 133–42
- Max M. H., Klamer T. W. Breast cancer in 120 women under 35 years old. A 10‐year community‐wide survey. Am Surg 1984; 50: 23–5
- Rosen P. P., Lesser M. L., Kinne D. W. Breast carcinoma at the extremes of age: a comparison of patients younger than 35 years and older than 75 years. J Surg Oncol 1985; 28: 90–6
- Colleoni M., Rotmensz N., Robertson C., et al. Very young women (<35 years) with operable breast cancer: features of disease at presentation. Ann Oncol 2002; 13: 273–9
- Tan P. H., Ho J. T. S., Ng E. H., et al. Pathologic‐radiologic correlations in screen detected ductal carcinoma in situ of the breast: findings of the Singapore breast screening project. Int J Cancer (Radiat Oncol Invest) 2000; 90: 231–6